寻常型天疱疮-话题@MedSci

#寻常型天疱疮#

10篇内容 | 1335人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2221515, encodeId=6da7222151503, content=<a href='/topic/show?id=49d9e10597b' target=_blank style='color:#2F92EE;'>#病理诊断#</a> <a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a> <a href='/topic/show?id=d88d11813411' target=_blank style='color:#2F92EE;'>#红斑水疱#</a>, objectTitle=皮肤常见天疱疮诊断要点及体会, objectType=article, longId=836663, objectId=469383666319, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240813/1723542214679_8538692.jpg, objectUrl=/article/show_article.do?id=469383666319, replyNumber=0, likeNumber=130, createdTime=2024-08-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=469383666319, moduleTitle=皮肤常见天疱疮诊断要点及体会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=469383666319)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1736308, encodeId=00851e36308e4, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=BJD：新生儿Fc受体抑制剂Efgartigimod治疗寻常型天疱疮和叶状天疱疮, objectType=article, longId=294991, objectId=c03429499136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c03429499136, replyNumber=0, likeNumber=101, createdTime=2022-08-24, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c03429499136, moduleTitle=BJD：新生儿Fc受体抑制剂Efgartigimod治疗寻常型天疱疮和叶状天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c03429499136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736305, encodeId=2fea1e3630538, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=Br J Dermatol：ST18在寻常型天疱疮中的致病作用, objectType=article, longId=294805, objectId=c657294805f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c657294805f3, replyNumber=0, likeNumber=93, createdTime=2022-12-19, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c657294805f3, moduleTitle=Br J Dermatol：ST18在寻常型天疱疮中的致病作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c657294805f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736307, encodeId=35ad1e3630762, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生, objectType=article, longId=294980, objectId=71b3294980b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71b3294980b1, replyNumber=0, likeNumber=88, createdTime=2022-02-14, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71b3294980b1, moduleTitle=JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71b3294980b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736306, encodeId=f07f1e363068d, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮, objectType=article, longId=294843, objectId=dbdb29484362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbdb29484362, replyNumber=0, likeNumber=89, createdTime=2022-03-13, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbdb29484362, moduleTitle=JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbdb29484362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736309, encodeId=3b3b1e36309c6, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究, objectType=article, longId=294997, objectId=b13929499ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b13929499ebf, replyNumber=0, likeNumber=102, createdTime=2022-10-20, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b13929499ebf, moduleTitle=BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b13929499ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736303, encodeId=db401e3630340, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=NEJM:利妥昔单抗vs吗替麦考酚酯治疗中重度寻常型天疱疮, objectType=article, longId=211617, objectId=97e321161e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e321161e56, replyNumber=0, likeNumber=90, createdTime=2022-02-07, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e321161e56, moduleTitle=NEJM:利妥昔单抗vs吗替麦考酚酯治疗中重度寻常型天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e321161e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736304, encodeId=7a0a1e36304e1, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=NEJM：利妥昔单抗vs.霉酚酸酯在寻常型天疱疮患者中的作用, objectType=article, longId=212854, objectId=cff5212854a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cff5212854a9, replyNumber=0, likeNumber=78, createdTime=2021-12-12, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff5212854a9, moduleTitle=NEJM：利妥昔单抗vs.霉酚酸酯在寻常型天疱疮患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cff5212854a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736302, encodeId=8bb61e36302ca, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=FDA授予DSG3-CAART治疗寻常型天疱疮的孤儿药资格, objectType=article, longId=187018, objectId=1bf918e01800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf918e01800, replyNumber=0, likeNumber=74, createdTime=2020-02-27, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf918e01800, moduleTitle=FDA授予DSG3-CAART治疗寻常型天疱疮的孤儿药资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf918e01800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736301, encodeId=b5c61e36301c5, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=罗氏CD20利妥昔单抗治疗寻常型天疱疮的III试验成功, objectType=article, longId=181544, objectId=65631815442f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65631815442f, replyNumber=0, likeNumber=100, createdTime=2020-02-02, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65631815442f, moduleTitle=罗氏CD20利妥昔单抗治疗寻常型天疱疮的III试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65631815442f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736300, encodeId=5dfe1e3630035, content=<a href='/topic/show?id=e745466e93c' target=_blank style='color:#2F92EE;'>#寻常型天疱疮#</a>, objectTitle=Lancet：10年研究显示利妥昔单抗治疗寻常型天疱疮可获得长期的疗效, objectType=article, longId=61919, objectId=9fb76191944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb76191944, replyNumber=0, likeNumber=85, createdTime=2016-12-13, rootId=0, userName=paperyu, userId=024034108725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb76191944, moduleTitle=Lancet：10年研究显示利妥昔单抗治疗寻常型天疱疮可获得长期的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fb76191944)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

寻常型天疱疮

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#病理诊断# #寻常型天疱疮# #红斑水疱#

皮肤常见天疱疮诊断要点及体会

2024-08-20发表于上海

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

BJD：新生儿Fc受体抑制剂Efgartigimod治疗寻常型天疱疮和叶状天疱疮

2022-08-24

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

Br J Dermatol：ST18在寻常型天疱疮中的致病作用

2022-12-19

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生

2022-02-14

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮

2022-03-13

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

BJD:大疱性类天疱疮和寻常型天疱疮患者的病因特异性死亡率研究

2022-10-20

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

NEJM:利妥昔单抗vs吗替麦考酚酯治疗中重度寻常型天疱疮

2022-02-07

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

NEJM：利妥昔单抗vs.霉酚酸酯在寻常型天疱疮患者中的作用

2021-12-12

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

FDA授予DSG3-CAART治疗寻常型天疱疮的孤儿药资格

2020-02-27

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

罗氏CD20利妥昔单抗治疗寻常型天疱疮的III试验成功

2020-02-02

paperyu (审核中...)

前往app查看评论内容

#寻常型天疱疮#

Lancet：10年研究显示利妥昔单抗治疗寻常型天疱疮可获得长期的疗效

2016-12-13

科室
- - 订阅+
  - 更多科室
工具
服务